Results 221 to 230 of about 1,466,333 (379)

Haemophilia Prophylaxis in the Age of Innovation: Exploring Opportunities for Personalized Treatment

Haemophilia, EarlyView.
ABSTRACT Introduction Recent advancements in haemophilia treatment have introduced a range of innovative therapies, including activated FVIII mimetics, ultra‐extended half‐life recombinant FVIII, rebalancing agents and gene therapy. These developments have transformed treatment options and expanded prophylaxis strategies.
Yesim Dargaud, Fabienne Volot, Stephanie Desage, Claire Pouplard, Valerie Chamouard, Anne Lienhart   +5 more
wiley   +1 more source

Recombinant bispecific antibodies for cancer therapy [PDF]

, 2005
Roland E. Kontermann
openalex   +1 more source

Targeting of peripheral blood T lymphocytes [PDF]

, 1996
Bolhuis, R.L.H. (Reinder), Gratama, J.W. (Jan-Willem), Hoogenboom, L.C.A.   +2 more
core   +1 more source

Recombinant approaches to IgG-like bispecific antibodies [PDF]

, 2005
Jonathan S. Marvin, Zhenping Zhu
openalex   +1 more source

European Principles of Nursing Care for Persons With Inherited Bleeding Disorders

Haemophilia, EarlyView.
ABSTRACT Introduction A nurse is one of the core members of the multidisciplinary haemophilia team. However, what people with inherited bleeding disorders (PwBD) can expect from them has not yet been formally defined. Aim This project, initiated by the EAHAD Nurses Committee, aimed to establish Principles of Nursing Care (PoNC) for PwBD to promote high‐
Nanda Uitslager, Mary Kavanagh, Maj Birkedal, Linda Myrin‐Westesson, the EAHAD Nurses Committee   +4 more
wiley   +1 more source

Targeting properties of an anti-CD16/anti-CD30 bispecific antibody in an in vivo system

, 2001
Christoph Renner, Ingo Stehle, Fook Thean Lee, Cathrine Hall, Bruno Catimel, Edouard C. Nice, Angela Mountain, Angela Rigopoulos, Martin W. Brechbiel, M. Pfreundschuh, Andrew M. Scott   +10 more
openalex   +1 more source

Experiences and Needs Regarding Information Provision in Children With Haemophilia: A Qualitative Study on Caregivers’ and Healthcare Providers’ Perspectives

Haemophilia, EarlyView.
ABSTRACT Introduction In haemophilia, ever more effective treatment options leading to minimal bleeding make information provision about the disease and its symptoms and when to alert the treatment team increasingly important. However, little is known about how current information provision is perceived and what the needs are.
Caroline M. A. Mussert, Nadia C. W. Kamminga, Evelien S. van Hoorn, Tjaisha M. Eekelaar, Silje R. Dehli, Carolien van der Velden‐van ‘t Hoff, Sasja Andeweg, Simone H. Reitsma, Annebelle C. M. Nooteboom, Adinda Diekstra, Armaĝan Albayrak, Marjon H. Cnossen, the SYMPHONY consortium   +12 more
wiley   +1 more source

TSUBASA Study: Evaluating Association of Physical Activity and Bleeding Events in People With Haemophilia A Without Factor VIII Inhibitors Receiving Emicizumab

Haemophilia, EarlyView.
ABSTRACT Background Emicizumab is approved for routine prophylaxis, but limited data exist investigating the relationship between bleeds and exercise in people with haemophilia A (PwHA) receiving emicizumab. Aim To evaluate the relationship between physical activity and bleeding outcomes in Japanese PwHA receiving emicizumab prophylaxis.
Kagehiro Amano, Teruhisa Fujii, Akihiro Sawada, Azusa Nagao, Chiai Nagae, Masanori Nojima, Nobuaki Suzuki, Mika Kawano, Tomomi Shimura, Yoshimasa Sugao, Naoto Hattori, Keiji Nogami   +11 more
wiley   +1 more source

Bispecific antibody for lung cancer: mechanisms and clinical insights. [PDF]

Front Immunol
Chen W, Zhou A, Zhou Y.
europepmc   +1 more source

Bispecific anti-CD20/22 antibodies inhibit B-cell lymphoma proliferation by a unique mechanism of action [PDF]

, 2007
Zhengxing Qu, David M. Goldenberg, Thomas M. Cardillo, Victoria Shi, Hans J. Hansen, Chien‐Hsing Chang   +5 more
openalex   +1 more source